Literature DB >> 2203676

Expression of high-affinity IL-4 receptors on murine tumour infiltrating lymphocytes and their up-regulation by IL-2.

R K Puri1, D S Finbloom, P Leland, H Mostowski, J P Siegel.   

Abstract

Since interleukin-2 (IL-2) and IL-4 act in concert to support the development of cytotoxic T lymphocytes (CTL) and the generation of antigen-specific tumour infiltrating lymphocytes (TIL), we investigated the interaction of these cytokines with an established TIL line. TIL proliferated in an additive fashion in response to suboptimal concentrations of IL-2 and various concentrations of IL-4. TIL possessed high-affinity IL-4 receptors whether cultured in recombinant IL-2 (rIL-2) or rIL-4, but cells cultured in rIL-2 had higher numbers of IL-4 receptors than cells cultured in rIL-4. When TIL were cultured in increasing concentrations of rIL-2, a dose-dependent enhancement in IL-4 receptor number was observed. The maximum induction of IL-4 receptor expression was achieved by 4 hr of incubation with rIL-2 and was completely blocked by cycloheximide. Other cytokines, such as rIL-1, recombinant tumour necrosis factor (rTNF), recombinant interferon-alpha (rIFN-alpha) and rIFN-gamma, had no effect on IL-4 receptor number. rIL-2 also up-regulated IL-4 receptors on CTLL-2, a murine CTL line. These data indicate that high-affinity IL-4 receptors exist on murine TIL and they can be up-regulated by IL-2. Our observation that IL-2 up-regulates IL-4 receptor may help explain the additive effects of these lymphokines on the proliferation of TIL and other cell lines. It may also help explain their co-operative effects on the generation of antigen-specific TIL and the differentiation of CTL.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2203676      PMCID: PMC1384254     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  20 in total

1.  IL-4 (B cell-stimulatory factor 1) regulates multiple aspects of influenza virus-specific cell-mediated immunity.

Authors:  D W Horohov; J A Crim; P L Smith; J P Siegel
Journal:  J Immunol       Date:  1988-12-15       Impact factor: 5.422

2.  Identification of a T cell-derived b cell growth factor distinct from interleukin 2.

Authors:  M Howard; J Farrar; M Hilfiker; B Johnson; K Takatsu; T Hamaoka; W E Paul
Journal:  J Exp Med       Date:  1982-03-01       Impact factor: 14.307

3.  Up-regulation of interleukin 4/B-cell stimulatory factor 1 receptor expression.

Authors:  J Ohara; W E Paul
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

4.  Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report.

Authors:  S A Rosenberg; B S Packard; P M Aebersold; D Solomon; S L Topalian; S T Toy; P Simon; M T Lotze; J C Yang; C A Seipp
Journal:  N Engl J Med       Date:  1988-12-22       Impact factor: 91.245

5.  Clonal analysis of T lymphocytes isolated from ovarian carcinoma ascitic fluid. Phenotypic and functional characterization of T-cell clones capable of lysing autologous carcinoma cells.

Authors:  S Ferrini; R Biassoni; A Moretta; M Bruzzone; A Nicolin; L Moretta
Journal:  Int J Cancer       Date:  1985-09-15       Impact factor: 7.396

6.  The characteristics of binding of human recombinant interferon-gamma to its receptor on human monocytes and human monocyte-like cell lines.

Authors:  D S Finbloom; D L Hoover; L M Wahl
Journal:  J Immunol       Date:  1985-07       Impact factor: 5.422

7.  Identification of interleukin 4 receptor-associated proteins and expression of both high- and low-affinity binding on human lymphoid cells.

Authors:  B M Foxwell; G Woerly; B Ryffel
Journal:  Eur J Immunol       Date:  1989-09       Impact factor: 5.532

8.  Interactions between receptors for interleukin 2 and interleukin 4 on lines of helper T cells (HT-2) and B lymphoma cells (BCL1).

Authors:  R Fernandez-Botran; V M Sanders; E S Vitetta
Journal:  J Exp Med       Date:  1989-02-01       Impact factor: 14.307

9.  Differential immune reactivity of tumour-intrinsic and peripheral-blood lymphocytes against autoplastic colorectal carcinoma cells.

Authors:  G H Hutchinson; D Heinemann; M O Symes; R C Williamson
Journal:  Br J Cancer       Date:  1981-09       Impact factor: 7.640

10.  Specific and non-specific lymphocyte cytotoxicity in colon carcinoma.

Authors:  B M Vose; P Gallagher; M Moore; P F Schofield
Journal:  Br J Cancer       Date:  1981-12       Impact factor: 7.640

View more
  3 in total

1.  Regulation by glutathione of interleukin-4 activity on cytotoxic T cells.

Authors:  S M Liang; N Lee; D S Finbloom; C M Liang
Journal:  Immunology       Date:  1992-03       Impact factor: 7.397

2.  Expression of high-affinity IL-4 receptors on human melanoma, ovarian and breast carcinoma cells.

Authors:  N I Obiri; J P Siegel; F Varricchio; R K Puri
Journal:  Clin Exp Immunol       Date:  1994-01       Impact factor: 4.330

3.  Expression of high affinity interleukin-4 receptors on human renal cell carcinoma cells and inhibition of tumor cell growth in vitro by interleukin-4.

Authors:  N I Obiri; G G Hillman; G P Haas; S Sud; R K Puri
Journal:  J Clin Invest       Date:  1993-01       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.